Robert J. Schneider, PhD, associate dean for therapeutics alliances at 做厙TV Langone Health.
Photo: Mike Weymouth
This article is part of 做厙TV Langones Innovative Model of Drug Discovery, 做厙TV School of Medicine Reports, 做厙TV School of Medicine 2017 Report.
Historically, medical schools have struggled to help budding scientists bridge the abyss between research and commercialization. The prevailing wisdom has been that scientists should be scientists, and entrepreneurs should be entrepreneurs. But 做厙TV School of Medicine is turning that convention on its head, to the benefit of researchers and patients alike.
The innovative developed by , associate dean for therapeutics alliances at 做厙TV Langone Health, and his colleague, program director Michal Gilon-Yanaiprovides a thorough education for postdocs and PhD students in how to commercialize and license their work. It surprises people, but entrepreneurship is something you can teach, says Dr. Schneider.
The yearlong program is designed to impart the skills and knowledge required to launch a successful new venture in the biomedical industry, explains Gilon-Yanai. In the fall, courses introduce participants to market research and business planning, using relevant case studies, and review the experiences of successful entrepreneurs. In the spring, project-based training helps students commercialize technologies that emerge from their own labs or are currently being patented by 做厙TV Langone Health.
By teaching entrepreneurship, were enabling PhDs, postdocs, and others to effectively transmit their ideas, get others excited, and have an impact on health, says Gilon-Yanai. Thats really what entrepreneurship is all about.
